B8F.DE - Biofrontera AG

XETRA - XETRA Delayed Price. Currency in EUR
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201612/31/201512/31/201412/31/2013
Total Revenue6,130.274,137.9173,095.5553,114.551
Cost of Revenue1,652.2471,235.5041,116.6861,603.7
Gross Profit4,478.0232,902.4131,978.8691,510.851
Operating Expenses
Research Development----
Selling General and Administrative----
Non Recurring----
Others----
Total Operating Expenses17,909.02914,368.86812,742.51210,252.289
Operating Income or Loss-11,778.759-10,230.951-9,646.957-7,137.738
Income from Continuing Operations
Total Other Income/Expenses Net----
Earnings Before Interest and Taxes-11,778.759-10,230.951-9,646.957-7,137.738
Interest Expense-1,207.022-1,168.551-1,149-1,271.081
Income Before Tax----
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops----
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-10,579.202-11,203.408-10,720.978-8,066.616
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares----